CYP3A5-mediated metabolism of midazolam in recombinant systems is highly sensitive to NADPH-cytochrome P450 reductase activity

Xenobiotica. 2011 Jan;41(1):1-5. doi: 10.3109/00498254.2010.523734. Epub 2010 Oct 18.


Data from in vitro drug metabolism studies with recombinant enzyme systems are frequently used to predict human drug metabolism in vivo. However, for the CYP3A probe substrate midazolam (MDZ), considerable variability in enzyme kinetic parameters has been observed in different in vitro studies. The aim of this study was to explore the effect of varying activities of the electron donor NADPH-cytochrome P450 reductase (CPR) on CYP3A5-mediated metabolism of MDZ. Microsomes with similar levels of CYP3A5 but 12-fold difference in CPR activity showed a 30-fold difference in intrinsic clearance for the formation of 1'-OH-MDZ. Significantly higher K(m) and lower V(max) for the formation of 1'-OH-MDZ were found in microsomes with low CPR activity compared with microsomes with higher CPR activity (P = 0.024 and 0.001). In the microsomes with lowest CPR activity, the formation of 1'-OH-MDZ displayed Michaelis-Menten kinetics, whereas substrate inhibition was observed in the two preparations with higher CPR activity. The present study shows that the CPR activity in different recombinant enzyme preparations is crucial for in vitro CYP3A5-mediated clearance of MDZ. This suggests that the CPR activity of enzyme preparations could be an important factor for the ability of in vitro data to predict human drug metabolism in vivo.

MeSH terms

  • Animals
  • Biocatalysis
  • Cell Line
  • Cytochrome P-450 CYP3A / metabolism*
  • Genetic Engineering
  • Humans
  • Insecta
  • Kinetics
  • Microsomes, Liver / enzymology
  • Midazolam / metabolism*
  • NADPH-Ferrihemoprotein Reductase / metabolism*
  • Recombination, Genetic*


  • CYP3A5 protein, human
  • Cytochrome P-450 CYP3A
  • NADPH-Ferrihemoprotein Reductase
  • Midazolam